ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
2,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
3,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
4,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
5,1,Headache,Headaches NEC,Headaches,Nerv,N
5,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
5,3,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
5,4,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
5,5,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
5,6,Thyroiditis,Acute and chronic thyroiditis,Thyroid gland disorders,Endo,N
5,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
7,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
7,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
8,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
8,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
8,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
9,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
10,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
11,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
11,2,Nephritis,Nephritis NEC,Nephropathies,Renal,N
12,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
13,1,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
14,1,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
15,1,Aphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
15,2,Bundle branch block left,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
15,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
15,4,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
15,5,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
15,6,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
15,7,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
15,8,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
15,9,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
16,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
16,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
16,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
16,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
16,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
16,6,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
16,7,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
16,8,Lung neoplasm,Respiratory tract and pleural neoplasms malignancy unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
16,9,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
17,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
17,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
17,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
17,4,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
18,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
19,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
19,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
19,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
19,4,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
19,5,Gastrointestinal vascular malformation haemorrhagic,Gastrointestinal vascular malformations,Gastrointestinal vascular conditions,Gastr,N
19,6,Helicobacter infection,Helicobacter infections,Bacterial infectious disorders,Infec,N
19,7,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
20,1,Acute interstitial pneumonitis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
21,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
22,1,Sarcoidosis,Acute and chronic sarcoidosis,Immune disorders NEC,Immun,N
23,1,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
24,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
24,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
24,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
25,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
25,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
25,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
25,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
26,1,Myasthenic syndrome,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
27,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,Y
28,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
28,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
28,3,Headache,Headaches NEC,Headaches,Nerv,N
28,4,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
29,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
30,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
31,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
32,1,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
32,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
33,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
33,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
33,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
34,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
35,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
35,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
35,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
36,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
36,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
37,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
37,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
37,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
37,4,Disability,Disability issues,Lifestyle issues,SocCi,N
37,5,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
37,6,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
37,7,Headache,Headaches NEC,Headaches,Nerv,N
37,8,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
37,9,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
37,10,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
38,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
39,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
39,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
40,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
40,2,Enteritis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
40,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
40,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
41,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
42,1,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
43,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
44,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
45,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
45,2,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,Y
45,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
46,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
46,2,Right ventricular failure,Right ventricular failures,Heart failures,Card,N
47,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
48,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
48,2,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
49,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
49,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
49,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
49,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
49,5,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
50,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
50,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
50,3,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
50,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
51,1,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
51,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
51,3,Hepatic pain,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
51,4,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
52,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
52,2,Myelitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
52,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
53,1,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
53,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
54,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
54,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
54,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
55,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
56,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
56,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
56,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
57,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
57,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
57,3,Sputum discoloured,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
58,1,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
58,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
58,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
58,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
58,5,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
58,6,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
59,1,C-reactive protein abnormal,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
59,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
59,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
59,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
59,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
60,1,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
61,1,Breast cancer metastatic,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,Y
61,2,Inflammatory carcinoma of the breast,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
62,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
63,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
64,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
65,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
65,2,Tumour marker increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
66,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
66,2,Hyperpyrexia,Febrile disorders,Body temperature conditions,Genrl,N
66,3,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
66,4,Neuroleptic malignant syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,Y
67,1,Adrenocortical insufficiency acute,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
68,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
68,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
69,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
69,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
69,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
69,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
70,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
70,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
70,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
70,4,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
71,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
71,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
72,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
72,2,Breast neoplasm,Breast neoplasms unspecified malignancy,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
72,3,Infected neoplasm,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
72,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
72,5,Tumour ulceration,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
73,1,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
73,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
74,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
74,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
74,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
74,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
75,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
76,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
77,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
77,2,Headache,Headaches NEC,Headaches,Nerv,N
78,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
78,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
79,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
80,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
80,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
81,1,Cerebellar ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
82,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
82,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
83,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
83,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
83,3,Malignant ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
84,1,Meningitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,Y
84,2,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
85,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
86,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
87,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
88,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
88,2,Pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
88,3,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
89,1,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
89,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
89,3,Pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
89,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
89,5,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
90,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
90,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
90,3,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
90,4,Osteosclerosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
91,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
92,1,Bone disorder,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
92,2,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
92,3,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
92,4,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
92,5,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
92,6,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
93,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
94,1,Autoimmune disorder,Autoimmune disorders NEC,Autoimmune disorders,Immun,N
94,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
94,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
95,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
95,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
96,1,Dermatomyositis,Connective tissue disorders,Epidermal and dermal conditions,Skin,N
97,1,Pneumonia bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
97,2,Pneumonia viral,Viral infections NEC,Viral infectious disorders,Infec,N
97,3,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
98,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
98,2,Headache,Headaches NEC,Headaches,Nerv,N
98,3,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
98,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
98,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
99,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
100,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
100,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
100,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
101,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
101,2,Nephritis,Nephritis NEC,Nephropathies,Renal,N
102,1,Headache,Headaches NEC,Headaches,Nerv,N
102,2,Polydipsia,Fluid intake increased,Electrolyte and fluid balance conditions,Metab,N
102,3,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
102,4,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
103,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
104,1,Immune-mediated lung disease,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
104,2,Inflammatory marker increased,Chemistry analyses NEC,Protein and chemistry analyses NEC,Inv,N
104,3,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
105,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
105,2,Immune-mediated lung disease,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
106,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
107,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
107,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
108,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
108,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
108,3,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
108,4,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
108,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
109,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
110,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
111,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
112,1,Schizoaffective disorder,Schizoaffective and schizophreniform disorders,Schizophrenia and other psychotic disorders,Psych,N
113,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
113,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
113,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
114,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
114,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
114,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
114,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
115,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
115,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
115,3,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
115,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
116,1,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
116,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
117,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
117,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
118,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
118,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
119,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
119,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
120,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
121,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
122,1,Nephritis,Nephritis NEC,Nephropathies,Renal,N
123,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
124,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
125,1,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
125,2,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
126,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
126,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
126,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
126,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
126,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
127,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
127,2,Crepitations,General signs and symptoms NEC,General system disorders NEC,Genrl,N
127,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
127,4,Heart failure with reduced ejection fraction,Left ventricular failures,Heart failures,Card,Y
127,5,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
127,6,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
127,7,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
127,8,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
128,1,Carpal tunnel syndrome,Mononeuropathies,Peripheral neuropathies,Nerv,N
129,1,Hepatocellular carcinoma,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
129,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
129,3,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
129,4,Temperature intolerance,Feelings and sensations NEC,General system disorders NEC,Genrl,N
130,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
130,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
130,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
130,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
130,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
130,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
131,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
131,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
131,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
131,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
131,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
131,6,Headache,Headaches NEC,Headaches,Nerv,N
131,7,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
131,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
131,9,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
131,10,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
131,11,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
132,1,Neutropenic colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
132,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
133,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
133,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
133,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
133,4,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
133,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
133,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
133,7,Headache,Headaches NEC,Headaches,Nerv,N
133,8,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
133,9,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
134,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
134,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
134,3,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
134,4,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
134,5,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
134,6,Vulvovaginal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
135,1,Alpha 1 foetoprotein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
135,2,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
136,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
136,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
137,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
137,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
137,3,Alopecia,Alopecias,Skin appendage conditions,Skin,N
137,4,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
137,5,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
137,6,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
137,7,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
137,8,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
137,9,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
137,10,Enterocolitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
137,11,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
137,12,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
137,13,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
137,14,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
137,15,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
137,16,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
137,17,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
137,18,Pancreatitis chronic,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
137,19,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
137,20,Terminal ileitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
137,21,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
137,22,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
138,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
138,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
139,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
140,1,Axillary pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
140,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
140,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
141,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
142,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
142,2,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
142,3,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
142,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
142,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
142,6,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
142,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
142,8,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
142,9,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
142,10,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
142,11,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
142,12,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
142,13,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
142,14,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
142,15,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
142,16,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
142,17,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
143,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
143,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
143,3,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
143,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
143,5,Gingivitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
143,6,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
143,7,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
143,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
143,9,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
143,10,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
143,11,Oral infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
144,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
144,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
144,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
144,4,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
144,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
144,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
144,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
144,8,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
144,9,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
144,10,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
144,11,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
145,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
145,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
145,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
145,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
146,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
147,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
147,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
148,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
149,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
149,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
150,1,Autoimmune nephritis,Nephritis NEC,Nephropathies,Renal,Y
151,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
151,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
151,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
151,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
151,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
151,6,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
151,7,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
152,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
152,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
153,1,Orbital oedema,"Orbital structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
154,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
154,2,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
154,3,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
155,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
155,2,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
156,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
156,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
156,3,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
156,4,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
156,5,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
156,6,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
156,7,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
156,8,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
156,9,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
156,10,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
156,11,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
156,12,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
156,13,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
156,14,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
156,15,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
156,16,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
156,17,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
156,18,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
156,19,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
156,20,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
156,21,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
156,22,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
156,23,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
156,24,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
156,25,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
156,26,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
156,27,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
156,28,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
156,29,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
156,30,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
156,31,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
157,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
157,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
158,1,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
159,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
159,2,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
160,1,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
161,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
161,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
161,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
161,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
161,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
161,6,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
162,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
163,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
163,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
163,3,Pharyngeal haemorrhage,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
164,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
164,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
164,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
164,4,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
164,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
164,6,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
164,7,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
164,8,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
164,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
165,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
166,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
166,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
166,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
166,4,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
166,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
166,6,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
166,7,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
166,8,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
166,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
167,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
167,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
168,1,Aphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
168,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
168,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
168,4,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
168,5,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
168,6,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
168,7,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
168,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
168,9,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
169,1,Cerebellar infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
169,2,Hepatocellular carcinoma,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
169,3,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
170,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
170,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
171,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
171,2,Upper limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
172,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
172,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
172,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
172,4,Urine output decreased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
173,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
173,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
174,1,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
174,2,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
175,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
176,1,Myasthenic syndrome,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
177,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
178,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
178,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
179,1,Sjogren's syndrome,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
180,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
181,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
182,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
183,1,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
184,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
185,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
186,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
186,2,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
187,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
187,2,Biliary tract disorder,Structural and other bile duct disorders,Bile duct disorders,Hepat,N
187,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
187,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
187,5,Immune-mediated hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
187,6,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
187,7,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
187,8,Tooth abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
188,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
189,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
190,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
190,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
191,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
191,2,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
192,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
193,1,Immune-mediated encephalitis,Encephalitis NEC,Central nervous system infections and inflammations,Nerv,N
194,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
195,1,Thyroiditis,Acute and chronic thyroiditis,Thyroid gland disorders,Endo,N
196,1,Blood phosphorus decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
197,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
197,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
198,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
199,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
199,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
200,1,Linear IgA disease,Bullous conditions,Epidermal and dermal conditions,Skin,N
201,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
201,2,Biliary tract disorder,Structural and other bile duct disorders,Bile duct disorders,Hepat,N
201,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
201,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
201,5,Immune-mediated hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
201,6,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
201,7,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
201,8,Tooth abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
202,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
203,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
204,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
205,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
206,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
206,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
206,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
206,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
206,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
207,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
207,2,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
208,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
209,1,Breast cancer recurrent,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
209,2,Headache,Headaches NEC,Headaches,Nerv,N
209,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
209,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
210,1,Headache,Headaches NEC,Headaches,Nerv,N
210,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
210,3,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
211,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
212,1,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,N
212,2,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,Y
212,3,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
212,4,Obstructive airways disorder,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
212,5,Pupil fixed,Pupil disorders,Ocular neuromuscular disorders,Eye,N
213,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
214,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
214,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
215,1,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
215,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
215,3,Urinary hesitation,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
216,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,Y
216,2,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
217,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
218,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
219,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
219,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
219,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
219,4,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
219,5,Hydronephrosis,Renal obstructive disorders,Renal disorders (excl nephropathies),Renal,N
219,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
220,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
221,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
222,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
222,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
222,3,Migraine,Migraine headaches,Headaches,Nerv,N
222,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
223,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
223,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
223,3,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
223,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
223,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
223,6,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
224,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
224,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
224,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
225,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
225,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
225,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
226,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
226,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
226,3,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
226,4,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
226,5,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
226,6,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
226,7,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
226,8,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
226,9,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
226,10,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
226,11,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
226,12,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
226,13,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
226,14,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
226,15,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
226,16,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
226,17,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
226,18,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
226,19,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
226,20,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
226,21,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
226,22,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
226,23,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
226,24,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
226,25,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
226,26,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
226,27,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
226,28,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
226,29,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
226,30,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
226,31,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
227,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
227,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
227,3,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
227,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
227,5,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
227,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
227,7,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
227,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
227,9,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
227,10,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
228,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
229,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
230,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
230,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
230,3,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
231,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
231,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
231,3,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
231,4,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
231,5,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
231,6,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
231,7,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
231,8,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
231,9,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
231,10,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
231,11,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
231,12,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
231,13,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
231,14,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
231,15,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
231,16,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
231,17,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
231,18,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
231,19,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
231,20,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
231,21,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
231,22,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
231,23,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
231,24,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
231,25,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
231,26,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
231,27,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
231,28,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
231,29,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
231,30,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
231,31,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
232,1,Cholangiocarcinoma,Bile duct neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
232,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
233,1,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
234,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
234,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
234,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
234,4,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
234,5,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
234,6,Death,Death and sudden death,Fatal outcomes,Genrl,N
234,7,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
234,8,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
234,9,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
234,10,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
234,11,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
234,12,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
234,13,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
234,14,Headache,Headaches NEC,Headaches,Nerv,N
234,15,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
234,16,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
234,17,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
234,18,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
234,19,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
234,20,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
234,21,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
234,22,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
234,23,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
234,24,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
234,25,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
234,26,Skin candida,Candida infections,Fungal infectious disorders,Infec,N
234,27,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
235,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
235,2,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
236,1,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
237,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
237,2,Gastric ulcer helicobacter,Helicobacter infections,Bacterial infectious disorders,Infec,N
237,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
237,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
237,5,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
237,6,Varices oesophageal,Oesophageal varices,Gastrointestinal vascular conditions,Gastr,N
238,1,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
238,2,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
239,1,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
240,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
240,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
241,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
241,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
241,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
242,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
243,1,Empyema,Infections NEC,Infections - pathogen unspecified,Infec,N
244,1,Deafness bilateral,Hearing losses,Hearing disorders,Ear,N
245,1,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
246,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
247,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
247,2,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
248,1,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
249,1,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
250,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
251,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
251,2,Migraine,Migraine headaches,Headaches,Nerv,N
251,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
252,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
253,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
253,2,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
254,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
255,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
255,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
255,3,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
256,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
257,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
257,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
257,3,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
257,4,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
257,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
257,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
257,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
257,8,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
258,1,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
259,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
259,2,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
260,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
261,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
262,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
263,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
263,2,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
263,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
264,1,Pelvic mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
265,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
265,2,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
265,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
266,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
266,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
267,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
267,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
267,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
267,4,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
267,5,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
268,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
269,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
269,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
269,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
270,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
270,2,Off label use of device,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
271,1,Anuria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
271,2,Diabetic foot infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
271,3,Dialysis hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
271,4,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
271,5,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
271,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
271,7,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
271,8,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
271,9,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
271,10,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
271,11,Peripheral vascular disorder,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
272,1,Diabetic foot infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
272,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
272,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
273,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
273,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
274,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
275,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
276,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
276,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
277,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
277,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
278,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
278,2,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
278,3,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
278,4,Periorbital swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
278,5,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
279,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
280,1,Ketoacidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
281,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
282,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
282,2,Weight bearing difficulty,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
283,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
283,2,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
283,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
283,4,Small cell lung cancer metastatic,Respiratory tract small cell carcinomas,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
284,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
